Literature DB >> 7945390

Cytotoxicity of 6-biopterin to human melanocytes.

K U Schallreuter1, G Büttner, M R Pittelkow, J M Wood, N N Swanson, C Körner.   

Abstract

(6R)5,6,7,8 tetrahydrobiopterin (6-BH4) is an important cofactor in the regulation of melanogenesis in melanocytes, where it controls: (a) the supply of L-tyrosine from L-phenylalanine via phenylalanine hydroxylase, and (b) regulates directly dopaquinone formation from L-tyrosine via tyrosinase. 6-BH4 undergoes redox-cycling by its oxidation to quinonoid dihydrobiopterin (qBH2) and to 6-biopterin through consecutive two electron oxidation reactions. The oxidized cofactor 6-biopterin (0.2 x 10(-6) M) is extremely cytotoxic to human melanocytes under in vitro conditions. Consequently, its reduction to 6-BH4 via q-BH2 is essential to melanocyte viability. In addition, the results herein show for the first time that human thioredoxin reductase has the capacity to reduce 6-biopterin to q-BH2 where further reduction to 6-BH4 follows via dihydropteridine reductase or reduced glutathione.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945390     DOI: 10.1006/bbrc.1994.2423

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

Review 1.  Highlights in pathogenesis of vitiligo.

Authors:  Ghada F Mohammed; Amal Ha Gomaa; Mohammed Saleh Al-Dhubaibi
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

2.  Defective calcium transport in vitiliginous melanocytes.

Authors:  K U Schallreuter-Wood; M R Pittelkow; N N Swanson
Journal:  Arch Dermatol Res       Date:  1996       Impact factor: 3.017

3.  Cloning and tissue expression of 6-pyruvoyl tetrahydropterin synthase and xanthine dehydrogenase from Poecilia reticulata.

Authors:  Jin Ben; Tit Meng Lim; Violet P E Phang; Woon-Khiong Chan
Journal:  Mar Biotechnol (NY)       Date:  2003-08-21       Impact factor: 3.619

Review 4.  Concise review of recent studies in vitiligo.

Authors:  Mohamed Allam; Hassan Riad
Journal:  Qatar Med J       Date:  2013-12-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.